© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Posted 18th February 2020

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Title21

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. From reporting to analytics, Title21 provides all the critical data at your fingertips so the right person has the right data at the right time to make the right decisions. This allows Medical Technologists, Technical and Medical Directors to focus on higher-value work, and ultimately the patient, rather than chasing down paperwork and people.

Earlier this year, Title21 was selected as the Most Outstanding Cell Therapy Software Provider for 2019 by AI’s Global Excellence Award. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Since their inception, Tile21’s Cloud and onpremise software manages critical patient, product and process data for cell and gene therapy, immunotherapy and regenerative medicine to ensure quality, compliance and traceability. Programs that implement Title21 solutions find they can scale more effectively to treat more patients and can also translate products more quickly and efficiently from bench to bedside, delivering the latest innovative therapies to patients faster and more safely.

Title21 has served FDA-regulated life science companies for many years with quality management software, so Title21’s experience has been of great service to the cell therapy segment. “Our technology is extremely flexible due to its configurability on the front end. That means that we can maintain a single code base while meeting each cancer center or cell manufacturers’ specific requirements.”

“Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day.”

“At Title21, we partner with the largest and top-rated cancer hospitals – placing the patient first. One of our greatest testimonials we hear often is that our customers want us to continue to solve more of their challenges with our technology. They ask Title21 to help provide solutions through technology to increase the quality, safety and efficiency of their programs.” Current Title21 customers have a strong influence on the technology roadmap to add value to patient therapeutic care and quality. Analytics and business intelligence are also important and play a significant role in the future of developing new cures and protocols more quickly and efficiently. Cell and gene therapy is a dynamic market and the protocols are changing rapidly as they are improved and refined.

Moving forward, the future looks bright for the team at Title21 as they continue to provide exceptional services and award-winning solutions to hospitals and biotech firms. “Our passion is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments to their patients. Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day” remarks Fischer.

Bringing the interview to a close, Lynn signs off by revealing the exciting plans which lie in the pipeline for the business, which includes their ambitions to further expand the business in the years to come, especially with the advancements in immunotherapy technology.

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
Challenging Blood Test Evidence in OWI/DUI Cases: Legal Strategies and Implications
News
29/08/2023Challenging Blood Test Evidence in OWI/DUI Cases: Legal Strategies and Implications

OWI or DUI blood tests are almost entirely based on a blood test as evidence. Such a test determines the presence of alcohol or drugs in the driver’s system. A blood test is one of the most accurate methods of measuring a person’s blood alcohol level (BAC)

Read Full PostRead - Eye Icon
Preventable Scald Injuries in Nursing Facilities: Risk Management, Compliance, and Legal Accountability
Legal
27/01/2026Preventable Scald Injuries in Nursing Facilities: Risk Management, Compliance, and Legal Accountability

Scald injuries in nursing facilities represent more than isolated accidents: they are often indicators of systemic operational failures, inadequate supervision, or lapses in safety compliance. For families, healthcare administrators, and legal professionals al

Read Full PostRead - Eye Icon
Things You Should Know If Someone Gets in an Accident With Your Car
Legal
27/06/2023Things You Should Know If Someone Gets in an Accident With Your Car

Lending your car to someone can be a stressful experience. Not only are they entrusted with something that cost quite a bit of money, but they’re also in possession of something that could potentially cause them and others extensive damage should an accident

Read Full PostRead - Eye Icon
Scams to be aware of as a professional
Strategy
06/05/2021Scams to be aware of as a professional

There are numerous opportunities to grow in the business world. You might start a company or look for the best places to invest money, but opportunities aren’t always what they seem to be. These are the most common scams to be aware of as a professional, so

Read Full PostRead - Eye Icon
Choosing the Right GPS Fleet Tracker Provider for Enterprise-level Operations
News
05/07/2024Choosing the Right GPS Fleet Tracker Provider for Enterprise-level Operations

Curious about GPS fleet trackers and their benefits for enterprise-level operations? This article explains the importance of GPS fleet trackers for businesses, including how they improve fleet management, increase efficiency, reduce costs, and enhance customer

Read Full PostRead - Eye Icon
Business Leaders of 2016
Leadership
01/07/2016Business Leaders of 2016

Regal Food Products Group Plc was established in the heart of Yorkshire in 2010 to cater for the growing needs of the South Asian consumer.

Read Full PostRead - Eye Icon
Economic Signals To Consider When Trading Forex In The Final Months Of 2022
Finance
11/10/2022Economic Signals To Consider When Trading Forex In The Final Months Of 2022

It’s a mantra that seems almost as old as time itself, but the ‘be fearful when others are greedy, and greedy when others are fearful’ strategy of Warren Buffett has served him well in more than five decades as an investor.

Read Full PostRead - Eye Icon
Quantitative Easing and How it Affects The UK Economy
Strategy
02/07/2020Quantitative Easing and How it Affects The UK Economy

Quantitative easing is a monetary policy used by the governments of nations during difficult economic times to boost the economy. Quantitative easing comes into play when a nation is grappling with drastic economic slowdown or recession.

Read Full PostRead - Eye Icon
How Business Leaders Can Use AI Without Losing Control
Leadership
18/03/2026How Business Leaders Can Use AI Without Losing Control

In this exclusive interview Andrew Ayres discusses the governance challenges created by AI, the risks organisations face at what he calls the “agentic edge,” and how leaders can build systems that combine innovation, accountability and human judgement in t



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow